Bursledon Hall
Blundell Lane
Southampton, Hampshire SO31 1AA
United Kingdom
Drug Safety Research Unit
COVID-19, vaccination, adverse events, thrombotic thrombocytopenia syndrome, treatment
Public health impact, Methodology, Pharmacovigilance, Regulatory action